AbInitio Bio
PrivateLast Round
Accelerator
Apr 1, 2026
Total Funding Raised
$520,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AbInitio Bio is a biotechnology company that develops foundation models to accelerate the manufacturing process of biologic-based drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AbInitio Bio Comparables
Compare AbInitio Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axio BioPharma | 69% | |
| CellType | 67% | |
| Algocell | 67% | |
AbInitio Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2026 | ||||
| Grant | Sep 1, 2025 | ||||
| Accelerator | Jun 1, 2025 |
AbInitio Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
| Fifty Years | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$500K raised from Y Combinator
- Sep 1, 2025
$20K grant round completed.
AbInitio Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AbInitio Bio's valuation, stock price, and market status.